Abstract
Glucocorticoid use is widespread in medicine. While it is often life-saving, side-effects are well known. The most common side-effect is osteoporosis. Today we have therapies with proven efficacy for the prevention of vertebral fractures and bone loss. Consequently recognition of glucocorticoid-induced osteoporosis is extremely important given the availability of effective therapy.
MeSH terms
-
Bone Density / drug effects
-
Bone Density Conservation Agents / therapeutic use*
-
Calcitonin / therapeutic use
-
Calcium, Dietary / therapeutic use
-
Diphosphonates / therapeutic use
-
Fluorides / therapeutic use
-
Glucocorticoids / adverse effects*
-
Hormone Replacement Therapy
-
Humans
-
Life Style
-
Osteoporosis / chemically induced*
-
Osteoporosis / physiopathology
-
Osteoporosis / prevention & control*
-
Risk Factors
-
Vitamin D / therapeutic use
Substances
-
Bone Density Conservation Agents
-
Calcium, Dietary
-
Diphosphonates
-
Glucocorticoids
-
Vitamin D
-
Calcitonin
-
Fluorides